Key statistics
Short selling activityProvided by S&P Global Market Intelligence
| Open | -- |
|---|---|
| High | -- |
| Low | -- |
| Bid | -- |
| Offer | -- |
| Previous close | 0.00 |
| Average volume | -- |
|---|---|
| Shares outstanding | 580.30m |
| Free float | 574.93m |
| P/E (TTM) | 34.22 |
| Market cap | 45.32bn USD |
| EPS (TTM) | 2.28 USD |
Data delayed at least 20 minutes, as of Feb 05 2021.
More ▼
Press releases
- Edwards Lifesciences to Host Earnings Conference Call on February 10, 2026
- Edwards Lifesciences to Present at the TD Cowen 46th Annual Health Care Conference
- Edwards Comments on JenaValve Acquisition
- FDA Approves Edwards Lifesciences' SAPIEN M3 Mitral Valve Replacement System as First Transseptal Transcatheter Therapy
- Edwards Lifesciences to Present at the 44th Annual J.P. Morgan Healthcare Conference
- Edwards Lifesciences Reaffirms Strategy for Sustainable, Differentiated Growth at Annual Investor Conference
- Edwards Champions American Heart Association Initiative to Reduce Deaths, Improve Care for Patients With Heart Valve Disease
More ▼
